[Significance of erythrocytic Kell antigen for predicting the development of congenital fetal malformations].
Bykova
E Ia
EIa
Andreeva
E I
EI
Purinia
G O
GO
Khemiĭ
L R
LR
D000017:ABO Blood-Group System / Q000235:genetics / Q000276:immunology; D000328:Adult; D002648:Child; D000013:Congenital Abnormalities / Q000097:blood / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D005819:Genetic Markers; D006801:Humans; D007626:Kell Blood-Group System / Q000235:genetics* / Q000276:immunology; D007844:Latvia / Q000453:epidemiology; D008297:Male; D011379:Prognosis; D012204:Rh-Hr Blood-Group System / Q000235:genetics / Q000276:immunology
D000017:ABO Blood-Group System; D005819:Genetic Markers; D007626:Kell Blood-Group System; D012204:Rh-Hr Blood-Group System
Znachenie éritrotsitarnogo antigena Kell v prognoze razvitiia vrozhdennykh porokov u ploda.